PHARMOPSIS
0896.277.228 · rovalta.com · 08/11/2026
ACTIVE
PHARMOPSIS
Financial year 2025 · Closed on 31/12/2025
Net result-33 k €-817,7 %over 1 year
Gross margin6,4 k €-83,8 %over 1 year
Equity593,2 k €-5,3 %over 1 year
Overview
Identity
Source · BCE/KBOPHARMOPSIS is a Private limited company incorporated in 2008. Its main activity is: Management consultancy activities. Its registered office is in Antwerpen.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0896.277.228
- Incorporation
- 07/03/2008
- Legal form
- Private limited company
- Registered office
- Entrepotkaai 2 box 801
2000 Antwerpen · FlandreSee on map - Contributed capital
- 2 000,00 €
- Latest accounts
- 31/12/2025
Activities (NACE)
Signals
Solid equityLow riskGood liquidityPositive EBITDA
Financials
Source · NBB, 17 filingsTrend over 17 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 6,4 k € | -83.8% | 39,9 k € | -27.1% | 54,7 k € | -64.4% | 153,4 k € | +20.5% | 127,3 k € |
| EBITDA | 6,3 k € | -84.1% | 39,3 k € | -27.8% | 54,5 k € | -64.5% | 153,3 k € | +20.7% | 127 k € |
| Operating result | -7,2 k € | -128% | 25,8 k € | -45.4% | 47,3 k € | -66.7% | 141,8 k € | +27.0% | 111,7 k € |
| Net result | -33 k € | -818% | 4,6 k € | -78.4% | 21,3 k € | -77.1% | 93,2 k € | +36.4% | 68,3 k € |
| Balance sheet | |||||||||
| Equity | 593,2 k € | -5.3% | 626,2 k € | +0.7% | 621,6 k € | +0.8% | 616,9 k € | +17.8% | 523,7 k € |
| Total assets | 698,5 k € | +1.3% | 689,2 k € | +7.2% | 643,1 k € | -12.2% | 732,4 k € | +19.8% | 611,5 k € |
| Cash | 5,9 k € | -69.2% | 19,3 k € | -20.3% | 24,2 k € | -52.1% | 50,4 k € | -13.4% | 58,2 k € |
| Debts | 105 k € | +67.3% | 62,7 k € | +192% | 21,5 k € | -81.4% | 115,5 k € | +31.6% | 87,8 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 100 k€ and 250 k€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Jan Hoflack | DirectorManager2018 accountsended |
Other companies at this address
Entrepotkaai 2 2000 Antwerpen| Company | CBE no. |
|---|---|
Aristotl● Active | 1018.326.784 |
BB Ventures● Active | 1028.080.927 |
BERT WEEMAES● Active | 0537.167.687 |
Broekhoven en Truyens Logistics● Bankrupt | 0763.533.916 |
EDDY RUSSO● Active | 0832.860.905 |
FOENKEL● Active | 0768.292.854 |
ILHOTA INVEST & CONSULT● Active | 1000.396.434 |
LUDWIG CALUWE● Active | 0479.559.783 |
Spotlight-Antwerp● Bankrupt | 0749.683.504 |
VDW NEXUS● Active | 1017.915.723 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 24/09/2026 | 30/09/2025 | 26/09/2024 | 29/09/2023 | 14/09/2022 | 20/09/2021 |
| General meeting | 04/05/2026 | 02/05/2025 | 03/05/2024 | 05/05/2023 | 06/05/2022 | 07/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 17 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 04/05/2026 | 24/09/2026 | Dutch | |
| Micro model | 31/12/2024 | 02/05/2025 | 30/09/2025 | Dutch | |
| Micro model | 31/12/2023 | 03/05/2024 | 26/09/2024 | Dutch | |
| Micro model | 31/12/2022 | 05/05/2023 | 29/09/2023 | Dutch | |
| Micro model | 31/12/2021 | 06/05/2022 | 14/09/2022 | Dutch | |
| Micro model | 31/12/2020 | 07/05/2021 | 20/09/2021 | Dutch | |
| Micro model | 31/12/2019 | 04/05/2020 | 06/11/2020 | Dutch | |
| Micro model | 31/12/2018 | 28/06/2019 | 29/08/2019 | Dutch | |
| Micro model | 31/12/2017 | 29/06/2018 | 25/09/2018 | Dutch | |
| Abridged model | 31/12/2016 | 30/06/2017 | 24/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 28/06/2016 | 12/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 02/05/2015 | 26/05/2016 | Dutch | |
| Abridged model | 31/12/2013 | 27/06/2014 | 11/07/2014 | Dutch | |
| Abridged model | 31/12/2012 | 30/06/2013 | 31/07/2013 | Dutch | |
| Abridged model | 31/12/2011 | 04/05/2012 | 04/06/2012 | Dutch | |
| Abridged model | 31/12/2010 | 06/05/2011 | 14/06/2011 | Dutch | |
| Abridged model | 31/12/2009 | 07/05/2010 | 17/06/2010 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 100 k€ and 250 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Jan Hoflack | DirectorManager2018 accountsended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Incorporation
Name
Registered office
Annual accounts
Filings17 filings
Mandates
Jan Hoflack
2008200920102011201220132014201520162017201820192020202120222023202420252026
PHARMOPSIS
Entrepotkaai 2 bte 801, 2000 Antwerp
Director
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Entrepotkaai 2 bte 801, 2000 AntwerpCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00529843 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| PHARMOPSISCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00529843 |
Events
- 2025Annual accounts 2025-33 k €↓
- 2024Annual accounts 20244,6 k €↓
- 2023Annual accounts 202321,3 k €↓
- 2022Annual accounts 202293,2 k €↑
- 2021Annual accounts 202168,3 k €↑
- 2020Annual accounts 202055,6 k €↓
- 2019Annual accounts 2019147,8 k €↑
- 2018Annual accounts 2018111,4 k €↑
- 2017Annual accounts 2017-171,9 k €↓
- 2016Annual accounts 2016121 k €↑
- 2015Annual accounts 201542,7 k €↑
- 2014Annual accounts 201411,9 k €↓
- 2013Annual accounts 201322,2 k €↓
- 2012Annual accounts 201242,8 k €↓
- 2011Annual accounts 201149,2 k €↓
- 2010Annual accounts 201063,9 k €↑
- 2009Annual accounts 2009228 €
- 07/03/2008IncorporationPrivate limited company